Announce Date | 05/08/2025 |
EPS Normalized Actual | $0.5 (Miss by $-0.285) |
EPS GAAP Actual | $0.5 (Miss by $-0.285) |
Revenue Actual | $2.3041B |
Revenue Surprise | Beat by $2304.1M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $2.00456 |
EPS GAAP Estimate | $2.00456 |
Revenue Estimate | $3.337344177B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 8.05 | 6.46 | 7.85082 | 8.24574 | 1 |
Dec 2028 | 7.57 | 6.87 | 7.57 | 7.57 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.6 | 0.6 | 2.3041B | -12.69% | 2304.1M |
FQ4 2024 (Dec 2024) | 1.4 | 1.4 | 2.7356B | -2.02% | 2735.6M |
FQ3 2024 (Sep 2024) | 3.88 | 3.88 | 3.0427B | -8.4% | 3042.7M |
FQ2 2024 (Jun 2024) | 2.03 | 2.03 | 3.2523B | -0.44% | 3252.3M |
FQ1 2024 (Mar 2024) | 0.98 | 0.98 | 2.5964B | 9.63% | 2596.4M |
FQ4 2023 (Dec 2023) | 0 | 0 | 2.7908B | 100% | 2790.8M |
FQ3 2023 (Sep 2023) | 1.99 | 1.99 | 3.2984B | 100% | 3298.4M |
FQ2 2023 (Jun 2023) | 1.58 | 1.58 | 3.2666B | 100% | 3266.6M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
2.00456
Consensus Revenue Estimates
3.337344177B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.362 | -- | 1.31756 | 1.40423 | 1 |
FQ3 2027 (Sep 2027) | 2.1267 | -- | 2.05732 | 2.19264 | 1 |
FQ2 2027 (Jun 2027) | 2.1482 | -- | 2.07812 | 2.21481 | 1 |
FQ1 2027 (Mar 2027) | 0.7585 | -- | 0.73375 | 0.78202 | 1 |
FQ4 2026 (Oct 2026) | 1.98473 | -- | 1.98473 | 1.98473 | 0 |
FQ3 2026 (Jul 2026) | 1.92791 | -- | 1.92791 | 1.92791 | 0 |
FQ2 2026 (Jun 2026) | 1.95731 | -- | 1.95731 | 1.95731 | 0 |
FQ1 2026 (Mar 2026) | 0.74224 | 19.16 | 0.74224 | 0.74224 | 0 |
FQ4 2025 (Oct 2025) | 1.92461 | 27.26 | 1.92461 | 1.92461 | 0 |
FQ3 2025 (Sep 2025) | 2.00456 | -93.56 | 2.00456 | 2.00456 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 2.81B | -- | 2.74B | 2.87B | 7 |
FQ3 2027 (Sep 2027) | 3.14B | -- | 3.06B | 3.22B | 4 |
FQ2 2027 (Jun 2027) | 3.32B | -- | 3.24B | 3.4B | 4 |
FQ1 2027 (Mar 2027) | 2.53B | -- | 2.47B | 2.59B | 7 |
FQ4 2026 (Oct 2026) | 3.3B | -- | 3.3B | 3.3B | 0 |
FQ3 2026 (Jul 2026) | 3.3B | -- | 3.3B | 3.3B | 0 |
FQ2 2026 (Jun 2026) | 3.35B | -- | 3.35B | 3.35B | 0 |
FQ1 2026 (Mar 2026) | 2.51B | 8.19 | 2.51B | 2.51B | 0 |
FQ4 2025 (Oct 2025) | 3.28B | 16.69 | 3.28B | 3.28B | 0 |
FQ3 2025 (Sep 2025) | 3.34B | 8.83 | 3.34B | 3.34B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.6 | 0.6 | 100% | |
FQ4 2024 (Dec 2024) | 1.4 | 1.4 | 100% | |
FQ3 2024 (Sep 2024) | 3.88 | 3.88 | 100% | |
FQ2 2024 (Jun 2024) | 2.03 | 2.03 | 100% | |
FQ1 2024 (Mar 2024) | 0.98 | 0.98 | 100% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | 1.99 | 1.99 | 100% | |
FQ2 2023 (Jun 2023) | 1.58 | 1.58 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $2.3B | $2304.1M | 100% |
FQ4 2024 (Dec 2024) | $0B | $2.74B | $2735.6M | 100% |
FQ3 2024 (Sep 2024) | $0B | $3.04B | $3042.7M | 100% |
FQ2 2024 (Jun 2024) | $0B | $3.25B | $3252.3M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.6B | $2596.4M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.79B | $2790.8M | 100% |
FQ3 2023 (Sep 2023) | $0B | $3.3B | $3298.4M | 100% |
FQ2 2023 (Jun 2023) | $0B | $3.27B | $3266.6M | 100% |